EGFR targeted therapy in lung cancer; an evolving story

Specific oncogenes with driver mutations, such as the Epidermal Growth Factor Receptor (EGFR 1) gene can lead to non-small-cell lung cancer formation. Identification of these oncogenes, their driver mutations and downstream effects allow the targeting of these pathways by drugs. Such personalised th...

Descripción completa

Detalles Bibliográficos
Autores principales: Bartholomew, C., Eastlake, L., Dunn, P., Yiannakis, D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2017
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5302182/
https://www.ncbi.nlm.nih.gov/pubmed/28217439
http://dx.doi.org/10.1016/j.rmcr.2017.01.016

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5302182/
https://www.ncbi.nlm.nih.gov/pubmed/28217439
http://dx.doi.org/10.1016/j.rmcr.2017.01.016

Ejemplares similares